| Figure 1‑1: Spinal Implant and VCF Market Share Ranking by Segment, U.S., 2023 (1 of 2) |
| Figure 1‑2: Spinal Implant and VCF Market Share Ranking by Segment, U.S., 2023 (2 of 2) |
| Figure 1‑3: Companies Researched in This Report (1 of 2) |
| Figure 1‑4: Companies Researched in This Report (2 of 2) |
| Figure 1‑5: Factors Impacting the Spinal Implant and VCF Market by Segment, U.S. (1 of 2) |
| Figure 1‑6: Factors Impacting the Spinal Implant and VCF Market by Segment, U.S. (2 of 2) |
| Figure 1‑7: Recent Events in the Spinal Implant and VCF Market, U.S., 2020 – 2024 |
| Figure 1‑8: Spinal Implant and VCF Procedures Covered (1 of 5) |
| Figure 1‑9: Spinal Implant and VCF Procedures Covered (2 of 5) |
| Figure 1‑10: Spinal Implant and VCF Procedures Covered (3 of 5) |
| Figure 1‑11: Spinal Implant and VCF Procedures Covered (4 of 5) |
| Figure 1‑12: Spinal Implant and VCF Procedures Covered (5 of 5) |
| Figure 1‑13: Procedure Codes Investigated |
| Figure 1‑14: Spinal Implant and VCF Markets Covered (1 of 4) |
| Figure 1‑15: Spinal Implant and VCF Markets Covered (2 of 4) |
| Figure 1‑16: Spinal Implant and VCF Markets Covered (3 of 4) |
| Figure 1‑17: Spinal Implant and VCF Markets Covered (4 of 4) |
| Figure 1‑18: Key Report Updates |
| Figure 1‑19: Version History |
| Figure 2‑1: Spinal Implant and VCF Market by Segment, Worst Case Scenario, U.S., 2023 – 2030 (US$M) |
| Figure 2‑2: Spinal Implant and VCF Market by Segment, Base Case Scenario, U.S., 2023 – 2030 (US$M) |
| Figure 2‑3: Spinal Implant and VCF Market by Segment, Best Case Scenario, U.S., 2023 – 2030 (US$M) |
| Figure 4‑1: Cervical Fixation Devices by Company (1 of 2) |
| Figure 4‑2: Cervical Fixation Devices by Company (2 of 2) |
| Figure 4‑3: Thoracolumbar Fixation Devices by Company (1 of 2) |
| Figure 4‑4: Thoracolumbar Fixation Devices by Company (2 of 2) |
| Figure 4‑5: Interbody Devices by Company (1 of 5) |
| Figure 4‑6: Interbody Devices by Company (2 of 5) |
| Figure 4‑7: Interbody Devices by Company (3 of 5) |
| Figure 4‑8: Interbody Devices by Company (4 of 5) |
| Figure 4‑9: Interbody Devices by Company (5 of 5) |
| Figure 4‑10: Artificial Disc Devices by Company |
| Figure 4‑11: Dynamic Stabilization Devices by Company |
| Figure 4‑12: Vertebral Body Tether Devices by Company |
| Figure 4‑13: Vertebral Compression Fracture Devices by Company |
| Figure 4‑14: Spinal Electrical Stimulation Devices by Company |
| Figure 4‑15: Spinal Surgery Instrumentation by Company |
| Figure 4‑16: Class 2 Device Recall Insignia" Anterior Cervical Plate System |
| Figure 4‑17: Class 2 Device Recall CervAlign Anterior Cervical Plate System |
| Figure 4‑18: Class 2 Device Recall Lineum OCT Spine System |
| Figure 4‑19: Class 2 Device Recall Medtronic Prestige LP(TM) Cervical Disc System with Streamlined Instruments, DRILL GUIDES |
| Figure 4‑20: Class 2 Device Recall Medtronic Sofamore Danek CD Horizon |
| Figure 4‑21: Class 2 Device Recall Polaris 5.5 Spinal System and Polaris 5.5/Cypher Spinal System |
| Figure 4‑22: Class 2 Device Recall Polaris 5.5 Spinal System and Polaris 5.5/Cypher Spinal System |
| Figure 4‑23: Class 2 Device Recall Vital MIS Spinal Fixation system |
| Figure 4‑24: Class 2 Device Recall Zimmer Biomet Vitality Spinal Fixation System |
| Figure 4‑25: Class 2 Device Recall Medtronic CD HORIZON Spinal System MULTIAXIAL SCREW FOR 5.5/6.0MM RODS |
| Figure 4‑26: Class 2 Device Recall LIF AMP, Adjustable Awl |
| Figure 4‑27: Class 2 Device Recall Catalyft" LS Expandable Interbody System Anterior Standalone Cage |
| Figure 4‑28: Class 2 Device Recall ALTERA Spacer |
| Figure 4‑29: Class 2 Device Recall Concorde Lift Expandable Interbody Device |
| Figure 4‑30: Class 2 Device Recall Boston Scientific Neuromodulation Corporation Superion IDS Kit |
| Figure 4‑31: Class 2 Device Recall Superion Indirect Decompression System (IDS) |
| Figure 4‑32: Class 2 Device Recall Prodisc C |
| Figure 4‑33: Class 2 Device Recall the MobiC Cervical Disc Prosthesis (MobiC; MobiC 14mm Distraction Screw) |
| Figure 4‑34: Class 2 Device Recall Medtronic Prestige LP(TM) Cervical Disc System with Streamlined Instruments, DRILL GUIDES |
| Figure 4‑35: Class 2 Device Recall Cortoss Bone Augmentation Material |
| Figure 4‑36: Class 2 Device Recall CEMENT MIXING SYSTEM |
| Figure 4‑37: Class 2 Device Recall BPB Medica CEMIX |
| Figure 4‑38: Class 2 Device Recall EASYNJECT, Device for CEMENT INFUSION in the VERTEBROPLASTY PROCEDURE |
| Figure 4‑39: Class 2 Device Recall DFINE Vertebral Assemblies |
| Figure 4‑40: Class 1 Device Recall SpF PLUSMini (60 A/W) Implantable Spinal Fusion Stimulator |
| Figure 4‑41: Cervical Fixation Surgery Cervical Collar for Management of Hirayama Disease: A Randomized Study |
| Figure 4‑42: Posterior Cervical Fixation Study |
| Figure 4‑43: An Investigation of the Metal Concentration in Patients Implanted with the PRESTIGE LP™ Cervical Disc at Two Contiguous Levels in the Cervical Spine |
| Figure 4‑44: Cervical Laminoplasty Versus Laminectomy and Fusion: The Long-term Results Comparison |
| Figure 4‑45: Quintex® Follow-up after One Year Minimum |
| Figure 4‑46: Safety and Efficacy Assessment of Using the zLOCK Facet Stabilization System |
| Figure 4‑47: Percutaneous Screw Fixation vs. Open Fixation in the Treatment of Thoracolumbar Fractures |
| Figure 4‑48: Comparison of Short Segment Mono-axial and Poly-axial Pedicle Screw Fixation for Thoracolumbar Fractures |
| Figure 4‑49: Adaptix RCT Evaluating Adaptix™ versus PEEK Cages |
| Figure 4‑50: A Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced |
| Figure 4‑51: Investigation of DEXA-C Anterior Cervical Interbody System (DEXA-C) |
| Figure 4‑52: Retro Comparison of Subsidence Following Interbody Devices in Lumbar Spine |
| Figure 4‑53: Bio2 Vitrium® Cervical Cage in Anterior Cervical Discectomy and Fusion |
| Figure 4‑54: Retro-prospective Clinical Study to Evaluate the Efficacy of the Stand-alone Cervical Interbody Cage C-CURVE (Peek and Titanium) Manufactured by MEDICREA® (C-CURVE) |
| Figure 4‑55: Postmarket Clinical Follow-Up Study on Arcadius XP L® Interbody Fusion Device (ARREST) |
| Figure 4‑56: Prospective Study of Fusion Rates Using Spira-C Device for Anterior Cervical Discectomy and Fusion Surgery (ACDF) |
| Figure 4‑57: SPIRA™-A 3D and HCT/p DBM vs. Medtronic Divergent™-L/Perimeter™ and Recombinant BMP-2 |
| Figure 4‑58: A Prospective Analysis of Long-Term Clinical Outcomes and 3D Spine Growth in Anterior Vertebral Body Tethering |
| Figure 4‑59: Real World Data Collection on the Synergy Cervical Disc |
| Figure 4‑60: The Tether™ – Vertebral Body Tethering System Post Approval Study |
| Figure 4‑61: Safety Outcomes of Vertebral Body Tethering Technique |
| Figure 4‑62: The Effect of Vertebral Body Tethering on Lumbar Paraspinal Muscle Cross-Section Area in Adolescent Idiopathic Scoliosis |
| Figure 4‑63: Study to Evaluate Safety and Effectiveness of Dynamic Stabilization Versus Lumbar Fusion in Treatment of Multilevel Lumbar Disc Degeneration Disease |
| Figure 4‑64: Percutaneous Vertebroplasty Using Rotary Cutter for Bone Metastases |
| Figure 4‑65: Early Percutaneous Vertebroplasty Versus Standard Conservative Treatment in Thoracolumbar Vertebral Fractures |
| Figure 4‑66: SpineJack System Postmarket Registry |
| Figure 4‑67: CT Guided Percutaneous Vertebroplasty for Vertebral Non-union Following Posterior Fixation |
| Figure 4‑68: Wearable Electrical Stimulation on the Back to Modulate Spinal Cord Activity |
| Figure 4‑69: Transcutaneous Electrical Spinal Stimulation to Restore Upper Extremity Functions in Spinal Cord Injury |
| Figure 4‑70: Study Using the CervicalStim Device Following Cervical Fusion |
| Figure 4‑71: Study Using the SpinalStim Device Following Lumbar Fusion Surgery |
| Figure 5‑1: Spinal Implant and VCF Market by Segment, U.S., 2023 – 2030 (US$M) |
| Figure 5‑2: Leading Competitors, Spinal Implant and VCF Market, U.S., 2023 |
| Figure 5‑3: SWOT Analysis, Aesculap |
| Figure 5‑4: SWOT Analysis, Alphatec Spine |
| Figure 5‑5: SWOT Analysis, Centinel Spine |
| Figure 5‑6: SWOT Analysis, DePuy Synthes |
| Figure 5‑7: SWOT Analysis, Globus Medical/NuVasive |
| Figure 5‑8: SWOT Analysis, Medtronic |
| Figure 5‑9: SWOT Analysis, Orthofix |
| Figure 5‑10: SWOT Analysis, Stryker |
| Figure 5‑11: SWOT Analysis, ZimVie/Highridge Medical |
| Figure 6‑1: Procedure Codes Investigated, U.S., 2023 |
| Figure 6‑2: Spine Procedures by Segment, U.S., 2023 – 2030 |
| Figure 6‑3: Cervical Fixation Procedures by Segment, U.S., 2023 – 2030 |
| Figure 6‑4: Total Levels Treated, Cervical Fixation, U.S., 2023 – 2030 |
| Figure 6‑5: Anterior Cervical Fixation Procedures by Segment, U.S., 2023 – 2030 |
| Figure 6‑6: Total Levels Treated, Anterior Cervical Fixation, U.S., 2023 – 2030 |
| Figure 6‑7: Total Anterior Cervical Fixation Procedures, U.S., 2023 – 2030 |
| Figure 6‑8: Constrained Anterior Cervical Fixation Procedures, U.S., 2023 – 2030 |
| Figure 6‑9: Semi-Constrained Anterior Cervical Fixation Procedures, U.S., 2023 – 2030 |
| Figure 6‑10: Dynamic Anterior Cervical Fixation Procedures, U.S., 2023 – 2030 |
| Figure 6‑11: Bioresorbable Anterior Cervical Fixation Procedures, U.S., 2023 – 2030 |
| Figure 6‑12: Anterior Cervical Fixation Procedures by Care Setting, U.S., 2023 – 2030 |
| Figure 6‑13: Posterior Cervical Fixation Procedures by Segment, U.S., 2023 – 2030 |
| Figure 6‑14: Total Levels Treated, Posterior Cervical Fixation, U.S., 2023 – 2030 |
| Figure 6‑15: Total Posterior Cervical Fixation Procedures, U.S., 2023 – 2030 |
| Figure 6‑16: Cable/Wiring Posterior Cervical Fixation Procedures, U.S., 2023 – 2030 |
| Figure 6‑17: Screw/Rod Posterior Cervical Fixation Procedures, U.S., 2023 – 2030 |
| Figure 6‑18: Occipitocervical Posterior Cervical Fixation Procedures, U.S., 2023 – 2030 |
| Figure 6‑19: Posterior Cervical Fixation Procedures by Care Setting, U.S., 2023 – 2030 |
| Figure 6‑20: Thoracolumbar Fixation Procedures by Segment, U.S., 2023 – 2030 |
| Figure 6‑21: Total Levels Treated, Cervical Fixation, U.S., 2023 – 2030 |
| Figure 6‑22: Degenerative Thoracolumbar Fixation Procedures by Segment, U.S., 2023 – 2030 |
| Figure 6‑23: Total Levels Treated, Degenerative Thoracolumbar Fixation, U.S., 2023 – 2030 |
| Figure 6‑24: Total Degenerative Thoracolumbar Fixation Procedures, U.S., 2023 – 2030 |
| Figure 6‑25: Anterior Degenerative Thoracolumbar Fixation Procedures, U.S., 2023 – 2030 |
| Figure 6‑26: Posterior Degenerative Thoracolumbar Fixation Procedures, U.S., 2023 – 2030 |
| Figure 6‑27: Degenerative Thoracolumbar Fixation Procedures by Levels Treated, U.S., 2023 – 2030 |
| Figure 6‑28: Deformity Correction Thoracolumbar Fixation Procedures, U.S., 2023 – 2030 |
| Figure 6‑29: Trauma/Tumor Thoracolumbar Fixation Procedures, U.S., 2023 – 2030 |
| Figure 6‑30: Interbody Procedures by Segment, U.S., 2023 – 2030 |
| Figure 6‑31: Total Levels Treated, Interbody, U.S., 2023 – 2030 |
| Figure 6‑32: ALIF Procedures by Material Type, U.S., 2023 – 2030 |
| Figure 6‑33: Total Levels Treated, ALIF, U.S., 2023 – 2030 |
| Figure 6‑34: Total ALIF Procedures, U.S., 2023 – 2030 |
| Figure 6‑35: Non-3D-Printed Metal ALIF Procedures, U.S., 2023 – 2030 |
| Figure 6‑36: PEEK ALIF Procedures, U.S., 2023 – 2030 |
| Figure 6‑37: Machined Bone ALIF Procedures, U.S., 2023 – 2030 |
| Figure 6‑38: 3D-Printed Metal ALIF Procedures, U.S., 2023 – 2030 |
| Figure 6‑39: ALIF Procedures by Care Setting, U.S., 2023 – 2030 |
| Figure 6‑40: PLIF Procedures by Material Type, U.S., 2023 – 2030 |
| Figure 6‑41: Total Levels Treated, PLIF, U.S., 2023 – 2030 |
| Figure 6‑42: Total PLIF Procedures, U.S., 2023 – 2030 |
| Figure 6‑43: Non-3D-Printed Metal PLIF Procedures, U.S., 2023 – 2030 |
| Figure 6‑44: PEEK PLIF Procedures, U.S., 2023 – 2030 |
| Figure 6‑45: Machined Bone PLIF Procedures, U.S., 2023 – 2030 |
| Figure 6‑46: 3D-Printed Metal PLIF Procedures, U.S., 2023 – 2030 |
| Figure 6‑47: PLIF Procedures by Care Setting, U.S., 2023 – 2030 |
| Figure 6‑48: TLIF Procedures by Material Type, U.S., 2023 – 2030 |
| Figure 6‑49: Total Levels Treated, TLIF, U.S., 2023 – 2030 |
| Figure 6‑50: Total TLIF Procedures, U.S., 2023 – 2030 |
| Figure 6‑51: Non-3D-Printed Metal TLIF Procedures, U.S., 2023 – 2030 |
| Figure 6‑52: PEEK TLIF Procedures, U.S., 2023 – 2030 |
| Figure 6‑53: Machined Bone TLIF Procedures, U.S., 2023 – 2030 |
| Figure 6‑54: 3D-Printed Metal TLIF Procedures, U.S., 2023 – 2030 |
| Figure 6‑55: TLIF Procedures by Care Setting, U.S., 2023 – 2030 |
| Figure 6‑56: CIF Procedures by Material Type, U.S., 2023 – 2030 |
| Figure 6‑57: Total Levels Treated, CIF, U.S., 2023 – 2030 |
| Figure 6‑58: Total CIF Procedures, U.S., 2023 – 2030 |
| Figure 6‑59: Non-3D-Printed Metal CIF Procedures, U.S., 2023 – 2030 |
| Figure 6‑60: PEEK CIF Procedures, U.S., 2023 – 2030 |
| Figure 6‑61: Machined Bone CIF Procedures, U.S., 2023 – 2030 |
| Figure 6‑62: 3D-Printed Metal CIF Procedures, U.S., 2023 – 2030 |
| Figure 6‑63: CIF Procedures by Care Setting, U.S., 2023 – 2030 |
| Figure 6‑64: VBR/Corpectomy Procedures by Material Type, U.S., 2023 – 2030 |
| Figure 6‑65: Total Levels Treated, VBR/Corpectomy, U.S., 2023 – 2030 |
| Figure 6‑66: Total VBR/Corpectomy Procedures, U.S., 2023 – 2030 |
| Figure 6‑67: Non-3D-Printed Metal VBR/Corpectomy Procedures, U.S., 2023 – 2030 |
| Figure 6‑68: PEEK VBR/Corpectomy Procedures, U.S., 2023 – 2030 |
| Figure 6‑69: 3D-Printed Metal VBR/Corpectomy Procedures, U.S., 2023 – 2030 |
| Figure 6‑70: VBR/Corpectomy Procedures by Care Setting, U.S., 2023 – 2030 |
| Figure 6‑71: Expandable Interbody Device Procedures by Material Type, U.S., 2023 – 2030 |
| Figure 6‑72: Total Levels Treated, Expandable Interbody Device, U.S., 2023 – 2030 |
| Figure 6‑73: Total Expandable Interbody Device Procedures, U.S., 2023 – 2030 |
| Figure 6‑74: Non-3D-Printed Metal Expandable Interbody Device Procedures, U.S., 2023 – 2030 |
| Figure 6‑75: PEEK Expandable Interbody Device Procedures, U.S., 2023 – 2030 |
| Figure 6‑76: 3D-Printed Metal Expandable Interbody Device Procedures, U.S., 2023 – 2030 |
| Figure 6‑77: Expandable Interbody Device Procedures by Care Setting, U.S., 2023 – 2030 |
| Figure 6‑78: Standalone Interbody Device Procedures by Material Type, U.S., 2023 – 2030 |
| Figure 6‑79: Total Levels Treated, Standalone Interbody Device, U.S., 2023 – 2030 |
| Figure 6‑80: Total Standalone Interbody Device Procedures, U.S., 2023 – 2030 |
| Figure 6‑81: Metal Standalone Interbody Device Procedures, U.S., 2023 – 2030 |
| Figure 6‑82: PEEK Standalone Interbody Device Procedures, U.S., 2023 – 2030 |
| Figure 6‑83: Standalone Interbody Device Procedures by Care Setting, U.S., 2023 – 2030 |
| Figure 6‑84: Interbody Procedures Performed by Segment, U.S., 2023 – 2030 |
| Figure 6‑85: Levels Treated by Segment, U.S., 2023 – 2030 |
| Figure 6‑86: Total Levels Treated, Non-3D-Printed Metal Interbody Procedures, U.S., 2023 – 2030 |
| Figure 6‑87: Total Levels Treated, Non-3D-Printed Metal Interbody Procedures, U.S., 2023 – 2030 |
| Figure 6‑88: PEEK Interbody Procedures by Segment, U.S., 2023 – 2030 |
| Figure 6‑89: Total Levels Treated, PEEK Interbody Procedures, U.S., 2023 – 2030 |
| Figure 6‑90: Machined Bone Procedures by Segment, U.S., 2023 – 2030 |
| Figure 6‑91: Total Levels Treated, Machined Bone Procedures, U.S., 2023 – 2030 |
| Figure 6‑92: 3D-Printed Metal Interbody Procedures by Segment, U.S., 2023 – 2030 |
| Figure 6‑93: Total Levels Treated, 3D-Printed Metal Interbody Procedures, U.S., 2023 – 2030 |
| Figure 6‑94: Motion Preservation Procedures by Segment, U.S., 2023 – 2030 |
| Figure 6‑95: Artificial Disc Procedures by Type, U.S., 2023 – 2030 |
| Figure 6‑96: Artificial Disc Procedures by Care Setting, U.S., 2023 – 2030 |
| Figure 6‑97: Dynamic Stabilization Procedures by Type, U.S., 2023 – 2030 |
| Figure 6‑98: Vertebral Compression Fracture Procedures by Segment, U.S., 2023 – 2030 |
| Figure 6‑99: Total Levels Treated, Vertebral Compression Fracture, U.S., 2023 – 2030 |
| Figure 6‑100: Vertebroplasty Procedures, U.S., 2023 – 2030 |
| Figure 6‑101: Vertebroplasty Procedures by Care Setting, U.S., 2023 – 2030 |
| Figure 6‑102: Percutaneous Vertebral Augmentation Procedures, U.S., 2023 – 2030 |
| Figure 6‑103: Percutaneous Vertebral Augmentation Procedures by Care Setting, U.S., 2023 – 2030 |
| Figure 6‑104: Spinal Electrical Stimulation Device Procedures, U.S., 2023 – 2030 |
| Figure 7‑1: Cervical Fixation Market by Segment, U.S., 2023 – 2030 (US$M) |
| Figure 7‑2: Anterior Cervical Fixation Market by Segment, U.S., 2023 – 2030 (US$M) |
| Figure 7‑3: Total Anterior Cervical Fixation Market, U.S., 2023 – 2030 |
| Figure 7‑4: Constrained Anterior Cervical Fixation Market, U.S., 2023 – 2030 |
| Figure 7‑5: Semi-Constrained Anterior Cervical Fixation Market, U.S., 2023 – 2030 |
| Figure 7‑6: Dynamic Anterior Cervical Fixation Market, U.S., 2023 – 2030 |
| Figure 7‑7: Bioresorbable Anterior Cervical Fixation Market, U.S., 2023 – 2030 |
| Figure 7‑8: Posterior Cervical Fixation Market by Segment, U.S., 2023 – 2030 (US$M) |
| Figure 7‑9: Total Posterior Cervical Fixation Market, U.S., 2023 – 2030 |
| Figure 7‑10: Cable/Wiring Posterior Cervical Fixation Market, U.S., 2023 – 2030 |
| Figure 7‑11: Screw/Rod Posterior Cervical Fixation Market, U.S., 2023 – 2030 |
| Figure 7‑12: Occipitocervical Posterior Cervical Fixation Market, U.S., 2023 – 2030 |
| Figure 7‑13: Leading Competitors, Cervical Fixation Market, U.S., 2023 |
| Figure 8‑1: Thoracolumbar Fixation Market by Segment, U.S., 2023 – 2030 (US$M) |
| Figure 8‑2: Degenerative Thoracolumbar Fixation Market by Approach, U.S., 2023 – 2030 (US$M) |
| Figure 8‑3: Total Degenerative Thoracolumbar Fixation Market, U.S., 2023 – 2030 |
| Figure 8‑4: Anterior Plating Degenerative Thoracolumbar Fixation Market, U.S., 2023 – 2030 |
| Figure 8‑5: Posterior Plating Degenerative Thoracolumbar Fixation Market, U.S., 2023 – 2030 |
| Figure 8‑6: Degenerative Thoracolumbar Fixation Market by Levels Treated, U.S., 2023 – 2030 (US$M) |
| Figure 8‑7: Single-Level Degenerative Thoracolumbar Fixation Market, U.S., 2023 – 2030 |
| Figure 8‑8: Two-Level Degenerative Thoracolumbar Fixation Market, U.S., 2023 – 2030 |
| Figure 8‑9: Multi-Level Degenerative Thoracolumbar Fixation Market, U.S., 2023 – 2030 |
| Figure 8‑10: Deformity Correction Thoracolumbar Fixation Market, U.S., 2023 – 2030 |
| Figure 8‑11: Trauma/Tumor Thoracolumbar Fixation Market, U.S., 2023 – 2030 |
| Figure 8‑12: Leading Competitors, Thoracolumbar Fixation Market, U.S., 2023 |
| Figure 9‑1: Interbody Device Market by Indication, U.S., 2023 – 2030 (US$M) |
| Figure 9‑2: Total Interbody Device Market, U.S., 2023 – 2030 |
| Figure 9‑3: ALIF Market by Material Type, U.S., 2023 – 2030 (US$M) |
| Figure 9‑4: Total ALIF Market, U.S., 2023 – 2030 |
| Figure 9‑5: Non-3D-Printed Metal ALIF Market, U.S., 2023 – 2030 |
| Figure 9‑6: PEEK ALIF Market, U.S., 2023 – 2030 |
| Figure 9‑7: Machined Bone ALIF Market, U.S., 2023 – 2030 |
| Figure 9‑8: 3D-Printed Metal ALIF Market, U.S., 2023 – 2030 |
| Figure 9‑9: PLIF Market by Material Type, U.S., 2023 – 2030 (US$M) |
| Figure 9‑10: Total PLIF Market, U.S., 2023 – 2030 |
| Figure 9‑11: Non-3D-Printed Metal PLIF Market, U.S., 2023 – 2030 |
| Figure 9‑12: PEEK PLIF Market, U.S., 2023 – 2030 |
| Figure 9‑13: Machined Bone PLIF Market, U.S., 2023 – 2030 |
| Figure 9‑14: 3D-Printed Metal PLIF Market, U.S., 2023 – 2030 |
| Figure 9‑15: TLIF Market by Material Type, U.S., 2023 – 2030 (US$M) |
| Figure 9‑16: Total TLIF Market, U.S., 2023 – 2030 |
| Figure 9‑17: Non-3D-Printed Metal TLIF Market, U.S., 2023 – 2030 |
| Figure 9‑18: PEEK TLIF Market, U.S., 2023 – 2030 |
| Figure 9‑19: Machined Bone TLIF Market, U.S., 2023 – 2030 |
| Figure 9‑20: 3D-Printed Metal TLIF Market, U.S., 2023 – 2030 |
| Figure 9‑21: CIF Market by Material Type, U.S., 2023 – 2030 (US$M) |
| Figure 9‑22: Total CIF Market, U.S., 2023 – 2030 |
| Figure 9‑23: Non-3D-Printed Metal CIF Market, U.S., 2023 – 2030 |
| Figure 9‑24: PEEK CIF Market, U.S., 2023 – 2030 |
| Figure 9‑25: Machined Bone CIF Market, U.S., 2023 – 2030 |
| Figure 9‑26: 3D-Printed Metal CIF Market, U.S., 2023 – 2030 |
| Figure 9‑27: Total VBR/Corpectomy Market, U.S., 2023 – 2030 |
| Figure 9‑28: VBR/Corpectomy Market by Material Type, U.S., 2023 – 2030 (US$M) |
| Figure 9‑29: Non-3D-Printed Metal VBR/Corpectomy Market, U.S., 2023 – 2030 |
| Figure 9‑30: PEEK VBR/Corpectomy Market, U.S., 2023 – 2030 |
| Figure 9‑31: 3D-Printed Metal VBR/Corpectomy Market, U.S., 2023 – 2030 |
| Figure 9‑32: VBR/Corpectomy Market by Anatomy, U.S., 2023 – 2030 (US$M) |
| Figure 9‑33: Cervical VBR/Corpectomy Market, U.S., 2023 – 2030 |
| Figure 9‑34: Lumbar VBR/Corpectomy Market, U.S., 2023 – 2030 |
| Figure 9‑35: VBR/Corpectomy Market by Device Type, U.S., 2023 – 2030 (US$M) |
| Figure 9‑36: Static VBR/Corpectomy Market, U.S., 2023 – 2030 |
| Figure 9‑37: Expandable VBR/Corpectomy Market, U.S., 2023 – 2030 |
| Figure 9‑38: Total Expandable Interbody Device Market, U.S., 2023 – 2030 |
| Figure 9‑39: Expandable Interbody Device Market by Material Type, U.S., 2023 – 2030 (US$M) |
| Figure 9‑40: Non-3D-Printed Metal Expandable Interbody Device Market, U.S., 2023 – 2030 |
| Figure 9‑41: PEEK Expandable Interbody Device Market, U.S., 2023 – 2030 |
| Figure 9‑42: 3D-Printed Metal Expandable Interbody Device Market, U.S., 2023 – 2030 |
| Figure 9‑43: Expandable Interbody Device Market by Approach, U.S., 2023 – 2030 (US$M) |
| Figure 9‑44: PLIF/TLIF Expandable Interbody Device Market, U.S., 2023 – 2030 |
| Figure 9‑45: LLIF Expandable Interbody Device Market, U.S., 2023 – 2030 |
| Figure 9‑46: Total Standalone Interbody Device Market, U.S., 2023 – 2030 |
| Figure 9‑47: Standalone Interbody Device Market by Material Type, U.S., 2023 – 2030 (US$M) |
| Figure 9‑48: Metal Standalone Interbody Device Market, U.S., 2023 – 2030 |
| Figure 9‑49: PEEK Standalone Interbody Device Market, U.S., 2023 – 2030 |
| Figure 9‑50: Standalone Interbody Device Market by Anatomy, U.S., 2023 – 2030 (US$M) |
| Figure 9‑51: Cervical Standalone Interbody Device Market, U.S., 2023 – 2030 |
| Figure 9‑52: Lumbar Standalone Interbody Device Market, U.S., 2023 – 2030 |
| Figure 9‑53: Standalone Interbody Device Market by Approach, U.S., 2023 – 2030 (US$M) |
| Figure 9‑54: ALIF Standalone Interbody Device Market, U.S., 2023 – 2030 |
| Figure 9‑55: LLIF Standalone Interbody Device Market, U.S., 2023 – 2030 |
| Figure 9‑56: Metal Interbody Device Market by Indication, U.S., 2023 – 2030 (US$M) |
| Figure 9‑57: Metal Interbody Device Market by Type, U.S., 2023 – 2030 (US$M) |
| Figure 9‑58: 3D-Printed Metal Interbody Device Market, U.S., 2023 – 2030 |
| Figure 9‑59: Non-3D-Printed Metal Interbody Device Market, U.S., 2023 – 2030 |
| Figure 9‑60: PEEK Interbody Device Market by Indication, U.S., 2023 – 2030 (US$M) |
| Figure 9‑61: PEEK Interbody Device Market by Type, U.S., 2023 – 2030 (US$M) |
| Figure 9‑62: Titanium-Coated PEEK Interbody Device Market, U.S., 2023 – 2030 |
| Figure 9‑63: Standard PEEK Interbody Device Market, U.S., 2023 – 2030 |
| Figure 9‑64: Machined Bone Interbody Device Market by Indication, U.S., 2023 – 2030 (US$M) |
| Figure 9‑65: Leading Competitors, Interbody Device Market, U.S., 2023 |
| Figure 10‑1: Motion Preservation Device Market by Segment, U.S., 2023 – 2030 (US$M) |
| Figure 10‑2: Artificial Disc Market by Segment, U.S., 2023 – 2030 (US$M) |
| Figure 10‑3: Total Artificial Disc Market, U.S., 2023 – 2030 |
| Figure 10‑4: Cervical Artificial Disc Market, U.S., 2023 – 2030 |
| Figure 10‑5: Lumbar Artificial Disc Market, U.S., 2023 – 2030 |
| Figure 10‑6: Dynamic Stabilization Device Market by Segment, U.S., 2023 – 2030 (US$M) |
| Figure 10‑7: Total Dynamic Stabilization Device Market, U.S., 2023 – 2030 |
| Figure 10‑8: Dynamic Posterior Stabilization Device Market, U.S., 2023 – 2030 |
| Figure 10‑9: Interspinous Process Stabilization Market, U.S., 2023 – 2030 |
| Figure 10‑10: Vertebral Body Tethering Market, U.S., 2023 – 2030 |
| Figure 10‑11: Leading Competitors, Motion Preservation Device Market, U.S., 2023 |
| Figure 11‑1: Vertebral Compression Fracture Market by Segment, U.S., 2023 – 2030 (US$M) |
| Figure 11‑2: Vertebral Compression Fracture Market, U.S., 2023 – 2030 |
| Figure 11‑3: Vertebroplasty Market, U.S., 2023 – 2030 |
| Figure 11‑4: Percutaneous Vertebral Augmentation Market, U.S., 2023 – 2030 |
| Figure 11‑5: Leading Competitors, Vertebral Compression Fracture Market, U.S., 2023 |
| Figure 12‑1: Electrical Stimulation Market by Segment, U.S., 2023 – 2030 (US$M) |
| Figure 12‑2: Electrical Stimulation Market, U.S., 2023 – 2030 |
| Figure 12‑3: Cervical Electrical Stimulation Market, U.S., 2023 – 2030 |
| Figure 12‑4: Lumbar Electrical Stimulation Market, U.S., 2023 – 2030 |
| Figure 12‑5: Leading Competitors, Electrical Stimulation Market, U.S., 2023 |
| Figure 13‑1: Spinal Surgery Instrumentation Market, U.S., 2023 – 2030 |
| Figure 13‑2: Leading Competitors, Spinal Surgery Instrumentation Market, U.S., 2023 |
